jkj...excellent perscective.

My bet as I've expressed many times is with the science, particularly with the remarable discoveries about the MOA of rvx-208 over the past 2 years. I believe positive discoveries re rvx-208 will continue in parallel with the BETonMACE trial. These discoveries will be enhanced by growth in the momentum of epigenetics and related science independent of RVX.

Where I feel RVX is sorely weak is in awareness and brand credibility, the lack of a high profile exchange such as NASDAQ and the inability to promote the company.

There are many reasons why the share price could increase before BoM results are announced such as another deal like Hepalink BUT having been around this stock for 8 years or so I am not holding my breath. As always I'd like to be proven wrong.

As per your post above having a very esteemed and high profile steering committee including Dr Steven Nicholls could enhance the credibility of rvx-208 if properly leveraged from a communications perspective...but this requires a concerted effort.

GLTA

Toinv